期刊文献+

体部伽玛刀治疗Ⅰ、Ⅱ期非小细胞肺癌疗效分析 被引量:2

Analysis of curative effect of Body-Gamma Knife radiotherapy in treating with stage I,II non-small cell lung cancer
原文传递
导出
摘要 目的:评价体部伽玛刀治疗Ⅰ、Ⅱ期非小细胞肺癌的疗效及毒副作用。方法52例Ⅰ期和Ⅱ期(T1-3N0M0)非小细胞肺癌患者接受国产旋转式体部伽玛刀治疗,治疗时用真空负压袋固定体位,CT定位扫描作三维计划。照射剂量肿瘤边缘(50%剂量线)4~5 Gy/次,5次/周,肿瘤局部总剂量40~50 Gy。结果原发灶近期完全缓解率CR为65.4%(34/52),部分缓解率PR为30.8%(16/52),稳定NR为1.9%(1/52),总有效率为98.1%(51/52)。52例全部按计划完成治疗,放射反应轻。放射性肺炎Ⅰ级占7.7%(4/52),Ⅱ级占3.8%(2/52),放射性食管炎:周围性肺癌0,中心型肺癌6例11.5%(6/52)。白细胞下降Ⅰ级占5.8%(3/52),Ⅱ级占1.9%(1/52)。1、2、3年总生存率分别为90.4%(47/52)、78.8%(41/52)、69.2(36/52)。结论体部伽玛刀治疗早期非小细胞肺癌近期疗效好,放射反应轻,能为患者耐受,是不能接受手术治疗的早期非小细胞肺癌的一种安全有效的局部治疗手段。 ObjectiveTo study the curative effect and side effect of Body-Gamma Knife radiotherapy in treating with 52 cases of stage I and stage II non-small cell lung cancer.Methods52 cases of non-small lung cancer in stage I and stage II (T1,2,3N0M0) were treated with rotary body gamma knife. Patients were fixed with vacuum bag, CT imitates to position and stereospic plan treatment. Irradiation dosage: tumor edge (50% dose line) 4-5 Gy/fraction, 5 times/week, total dose of tumor 40-50Gy. ResultsThe recent complete remission rate of primary lesion is CR 65.3%(34/52); partial remission rate is PR30.7%(16/52),while 0.01%(1/52) is no remission. Overall response rate is 98.0%(51/52). All the 52 cases were complete treatment on schedule with less complications of radiotherapy, 0.07%(4/52) with stage I radiation pneumonitis, 0.03%(2/52) with stage II radiation pneumonitis, 11.5%(6/52) with radiation esophagitis, 0.05%(3/52)with stage I leucopenia and 0.01%(1/52)with stage II leucopenia. The 1, 2, 3-year survival rate is 90.3%(47/52), 78.8%(41/52), 69.2(36/52),respectively.ConclusionBody-Gamma Knife, with good sort-term effects and less radiotherapy complications, is an useful and safety way in treating with early-stage non-small cell lung cancer who with surgical contraindication.
机构地区 解放军
出处 《中国临床实用医学》 2014年第2期6-8,共3页 China Clinical Practical Medicine
关键词 I II期非小细胞肺癌 体部伽玛刀 疗效分析 Stage I,II non-small cell lung cancer Body-Gamma Knife Curative effect analysis
  • 相关文献

同被引文献31

  • 1尹波,杨艳.早期非小细胞肺癌21例非手术治疗观察[J].基层医学论坛,2006,10(1):39-39. 被引量:1
  • 2刘泰福.现代放射治疗学[M].上海:上海医科大学出版社,2001:555-602. 被引量:12
  • 3Wisnivesky J P, Bonomi M, Hensehke C, et al.Radiation therapy for the treatment of unresected stage I-IT non-small cell lung cancer[J]. Chest, 2005, 128 ( 3 ) : 1461-1467. 被引量:1
  • 4Nanke T, Goya T, Tsuchiya R, et al.Prognosis and survival in resected lung carcinoma based on the new international staging system[J].J Thorae Cardiovase Surg, 1988, 96 ( 3 ) : 440-447. 被引量:1
  • 5Robinson C G, Dewees T A, Elnaqa I M, et al.Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer[J].J Thorac Oncol, 2013, 8 ( 2 ): 192-201. 被引量:1
  • 6Crabtree T D, Denlingr C E, Meyers B F, et al.Stereotactic body radiation therapy versus surgical resection for stage I non-small-cell lung cancer[J].J Thorac Cardiovasc Surg, 2010, 140 ( 2 ) : 377- 386. 被引量:1
  • 7Schulte T, Schniewind B, Dohrmann P, et al.The extent of lung parenchyma resection significantly impacts long-term quality of life in patients with non small cell lung cancer[J].Chest, 2009, 135 ( 2 ) : 322-329. 被引量:1
  • 8Nguyen N P, Garlang L, Welsh J, et al.Can stereotactic fraetionated radiation therapy become the standard of care for early stage non-small eel1 lung earcinoma[J].Cancer Treat Rev, 2008, 34 ( 8 ) : 719-727. 被引量:1
  • 9Li Rui, Chenwei-chang, Wang Wei-peng, et al. Antioxidant activity of astragalus polysaccharides and antitumouractivity of the polysac- charides and siRNA [ J ]. Carbohydrate polymers, 2010,82 ( 2 ) : 240-244. 被引量:1
  • 10Williams JP, Brown SL, Georges GE, et al. Animal models for med- ical to radiation exposure [ J ]. Rad Res ,2010,173 (4) :557-558. 被引量:1

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部